fig2
From: Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience
![Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience](https://image.oaes.cc/35ea7333-b66c-4630-9a7a-d1d185f962d7/2850.fig.2.png)
Figure 2. Percentage of improvement (green), stability (blue) o worsening (red) of biochemical parameters. AST: aspartate-amino-transferase; ALT: alanine-amino-transferase; ALP: alkaline phosphatase; GGT: gamma-glutamil-transferase; AFP: α-fetoprotein; WBC: white blood cells; PT: prothrombin time